CODAC Behavioral Health Services, Inc.

codac.org

CODAC is one of Arizona’s oldest and most respected community providers of specialty care for mental illness, addiction and trauma. What began as a grassroots drug abuse prevention program has grown into a multi-faceted organization that provides services across the entire spectrum of behavioral health care. Through 11 service locations and over 400 staff and volunteers, CODAC now serves more than 15,000 individuals and families each year. CODAC is a nonprofit 501(C)(3) organization. We are here to help you meet your mental health, substance abuse, trauma, primary care and general wellness goals. A variety of treatment professionals will partner with you to develop a plan and take positive steps toward a healthy, productive, caring life in recovery from a mental illness, substance use disorder and/or trauma.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

SOCIETAL CDMO SELECTED TO PROVIDE TECH TRANSFER AND MANUFACTURING SERVICES TO SUPPORT CLINICAL DEVELOPMENT OF AN ORAL SOLID DOSE PRODUCT IN EUROPE

Societal CDMO, Inc. | July 21, 2022

news image

Societal CDMO, Inc. a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that it has been selected to provide CDMO services to support the ongoing clinical development of a novel drug candidate in Europe. The compound is an oral solid dose anti-viral therapy product approved for the prevention and treatment of human immunodeficiency virus in select countries...

Read More

USANA LAUNCHES NEW, CUTTING-EDGE MOOD AND RELAXATION PRODUCT LINE AT AMERICAS AND EUROPE VIRTUAL CONVENTION

Prnewswire | August 18, 2020

news image

Managing occasional stress and keeping a calm mind are vital for navigating today's world. And USANA's new Mood and Relaxation product line is designed to help. The company's annual Americas and Europe Convention went virtual this year, and USANA continued to impress with the launch of its new Stress Relief mood-support supplement and Calm Response essential oil balm. These products take a natural and mindful approach to overall health and well-being.* To find out more about USANA an...

Read More

Pharmacy Market

ACORDA THERAPEUTICS ENTERS INTO LICENSE AGREEMENT WITH ASIERIS PHARMACEUTICALS

Asieris | August 30, 2022

news image

Acorda Therapeutics, Inc. announced that it has entered into a license agreement relating to its preclinical asset, Nepicastat, with Asieris Pharmaceuticals, a biotechnology company headquartered in China. Under the terms of the agreement, Acorda will receive an upfront payment of $500,000, and up to an additional $7 million based on the achievement of regulatory milestones. Acorda will also receive a royalty on future net sales. Nepicastat is a small molecule drug and the license...

Read More

Pharmacy Market

GINKGO BIOWORKS ADVANCES COLLABORATION WITH NOVO NORDISK ON EXPRESSION SYSTEMS FOR PHARMACEUTICAL PRODUCTS

PRNewswire | July 13, 2023

news image

Ginkgo Bioworks which is building the leading platform for cell programming and biosecurity, today announced the completion of the pilot phase of their previously announced partnership with Novo Nordisk, a leading global healthcare company, to develop expression systems for pharmaceutical products. With the pilot phase completed and the first milestone achieved, the two companies will now move into the development phase to work towards making a more effective production process. Achievemen...

Read More
news image

Business Insights

SOCIETAL CDMO SELECTED TO PROVIDE TECH TRANSFER AND MANUFACTURING SERVICES TO SUPPORT CLINICAL DEVELOPMENT OF AN ORAL SOLID DOSE PRODUCT IN EUROPE

Societal CDMO, Inc. | July 21, 2022

Societal CDMO, Inc. a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that it has been selected to provide CDMO services to support the ongoing clinical development of a novel drug candidate in Europe. The compound is an oral solid dose anti-viral therapy product approved for the prevention and treatment of human immunodeficiency virus in select countries...

Read More
news image

USANA LAUNCHES NEW, CUTTING-EDGE MOOD AND RELAXATION PRODUCT LINE AT AMERICAS AND EUROPE VIRTUAL CONVENTION

Prnewswire | August 18, 2020

Managing occasional stress and keeping a calm mind are vital for navigating today's world. And USANA's new Mood and Relaxation product line is designed to help. The company's annual Americas and Europe Convention went virtual this year, and USANA continued to impress with the launch of its new Stress Relief mood-support supplement and Calm Response essential oil balm. These products take a natural and mindful approach to overall health and well-being.* To find out more about USANA an...

Read More
news image

Pharmacy Market

ACORDA THERAPEUTICS ENTERS INTO LICENSE AGREEMENT WITH ASIERIS PHARMACEUTICALS

Asieris | August 30, 2022

Acorda Therapeutics, Inc. announced that it has entered into a license agreement relating to its preclinical asset, Nepicastat, with Asieris Pharmaceuticals, a biotechnology company headquartered in China. Under the terms of the agreement, Acorda will receive an upfront payment of $500,000, and up to an additional $7 million based on the achievement of regulatory milestones. Acorda will also receive a royalty on future net sales. Nepicastat is a small molecule drug and the license...

Read More
news image

Pharmacy Market

GINKGO BIOWORKS ADVANCES COLLABORATION WITH NOVO NORDISK ON EXPRESSION SYSTEMS FOR PHARMACEUTICAL PRODUCTS

PRNewswire | July 13, 2023

Ginkgo Bioworks which is building the leading platform for cell programming and biosecurity, today announced the completion of the pilot phase of their previously announced partnership with Novo Nordisk, a leading global healthcare company, to develop expression systems for pharmaceutical products. With the pilot phase completed and the first milestone achieved, the two companies will now move into the development phase to work towards making a more effective production process. Achievemen...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us